U
ELV icon

UBS’s Elevance Health ELV Stock Holding History

UBS’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$945K Buy
7,900
+3,500
+80% +$401K ﹤0.01% 3644
2014
Q2 		$473K Sell
4,400
-2,400
-35% -$247K ﹤0.01% 4275
2014
Q1 		$677K Sell
6,800
-30,900
-82% -$2.79M ﹤0.01% 3920
2013
Q4 		$3.48M Buy
37,700
+19,500
+107% +$1.73M ﹤0.01% 2228
2013
Q3 		$1.52M Sell
18,200
-600
-3% -$51.4K ﹤0.01% 2885
2013
Q2 		$1.54M Buy
+18,800
New +$1.41M ﹤0.01% 2851

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

UBS's ELV Position: Q3 2014 in Review

UBS increased its Elevance Health (ELV) stake by 2.3% in Q3 2014, buying an estimated $555K and bringing the position to 216,513 shares worth $25.9M. The position accounts for 0.02% of the portfolio, ranked #795.

UBS first reported a position in ELV in Q2 2013 and has held it in 6 quarters since. The position peaked at $31.7M in Q1 2014. 706 funds tracked by Wall St. Rank hold ELV as of Q3 2014.

  • UBS held 216,513 shares of Elevance Health worth $25.9M as of Q3 2014.
  • UBS bought 4,839 Elevance Health shares in Q3 2014, an estimated $555K.
  • Elevance Health made up 0.02% of UBS's portfolio in Q3 2014, its #795 holding.
  • UBS first reported a position in Elevance Health in Q2 2013 and has held it in 6 quarters since.
  • UBS's Elevance Health position peaked at $31.7M in Q1 2014.
  • 706 funds tracked by Wall St. Rank held Elevance Health as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.